BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for 89bio, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 4:07 pm Sale | 2024-12-31 | 13G | 89bio, Inc. ETNB | BIOTECHNOLOGY VALUE FUND L P | 4,333,885 3.600% | -2,477,746 (-36.38%) | Filing |
| 2024-11-14 4:30 pm Sale | 2024-09-30 | 13G | 89bio, Inc. ETNB | BIOTECHNOLOGY VALUE FUND L P | 6,811,631 6.400% | -756,849 (-10.00%) | Filing |
| 2024-02-14 09:58 am Purchase | 2023-12-31 | 13G | 89bio, Inc. ETNB | BIOTECHNOLOGY VALUE FUND L P | 7,568,480 7.800% | 4,047,354 (+114.94%) | Filing |
| 2023-02-14 12:00 pm Sale | 2022-12-31 | 13G | 89bio, Inc. ETNB | BIOTECHNOLOGY VALUE FUND L P | 3,521,126 6.500% | -376,874 (-9.67%) | Filing |
| 2022-07-11 5:03 pm Purchase | 2022-06-29 | 13G | 89bio, Inc. ETNB | BIOTECHNOLOGY VALUE FUND L P | 3,898,000 9.990% | 3,898,000 (New Position) | Filing |